Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA4503 in acute ischemic stroke
NCT00639249Phase 2Completed
- Sponsor
- M's Science Corporation
- Start
- Feb 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cutamesine in ischemic stroke, sponsored by M's Science Corporation. Started Feb 2008; status: completed.
02
Drugs
cutamesine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00639249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00639249.